DUBLIN--(BUSINESS WIRE)--The "Kidney Transplantation Therapeutics Market by Product and Geography - Global Forecast and Analysis 2019-2023" report has been added to ResearchAndMarkets.com's offering.
The global kidney transplantation therapeutics market report looks at factors such as the rising prevalence of CKD and renal impairments, availability of drugs in multiple dosage forms, and high dependency on immunosuppressants for kidney transplantations. However, side-effects of immunosuppressants, demand-supply imbalance, and stringent regulatory guidelines may hamper the growth of the kidney transplantation therapeutics industry over the forecast period.
The kidney transplantation therapeutics market analysis considers sales from selective cytokine inhibitors, immunosuppressive antimetabolites, and other drugs. In 2018, the selective cytokine inhibitors segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as superior immunosuppressive capabilities will play a significant role in the selective cytokine inhibitors segment to maintain its market position.
Global Kidney Transplantation Therapeutics Market: Overview
High dependency on immunosuppressants for kidney transplantation
Significant advances in surgical techniques and ancillary healthcare techniques are increasing the demand for kidney transplantation. To overcome the challenge of transplant rejection, vendors have developed immunosuppressants. Thus, to reduce the risk and probability of the transplanted organ getting rejected, patients must undergo maintenance therapy using these immunosuppressants for the rest of their lives. This increase in the kidney transplantation and risks associated raises the demand for immunosuppressants leading to the expansion of the global kidney transplantation therapeutics market at a CAGR of over 4% during the forecast period.
Reimbursement policies for kidney transplantation
Patient assistance programs make drugs affordable for patients. These programs are associated with both government and non-government organizations. The Patient Protection and Affordable Care Act aims to improve the quality of health care by providing affordable health insurance. Similarly, the Medicare insurance coverage is expected to enable patients to take immunosuppressants on daily basis to reduce the risk of transplant rejection for years after the transplantation as it is challenging to afford the costs associated with this therapy. Such initiatives are expected to have a positive impact on the overall market growth.
Competitive Landscape
With the presence of several major players, the global kidney transplantation therapeutics market is fragmented. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading kidney transplantation therapeutics manufacturers, that include Astellas Pharma Inc., F. Hoffmann-La Roche Ltd., Mylan NV, Novartis AG, Veloxis Pharmaceuticals A/S.
Key Topics Covered:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Selective cytokine inhibitors - Market size and forecast 2018-2023
- Immunosuppressive antimetabolites - Market size and forecast 2018-2023
- Other drugs - Market size and forecast 2018-2023
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: MARKET TRENDS
- Novel techniques for kidney transplantation
- Reimbursement policies for kidney transplantation
- Increasing strategic alliances
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Astellas Pharma, Inc.
- F. Hoffmann-La Roche Ltd.
- Mylan NV
- Novartis AG
-
Veloxis Pharmaceuticals A/S
For more information about this report visit https://www.researchandmarkets.com/r/fym64t
